Phase 2 Ischaemic heart disease Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Not Yet Recruiting
Phase 2
Use of heparin to prevent lung microvascular thrombosis in patients administered aprotinin undergoing cardiac surgery for ischemic heart disease
Ischaemic heart disease
St. Vincents Hospital Melbourne20 enrolled1 locationACTRN12606000328572
Completed
Phase 2
Granulocyte-colony stimulating factor (G-CSF) mobilised autologous endothelial progenitor cells for refractory ischaemic heart disease
Patients with chronic ischaemic heart disease (IHD) on maximal medical therapy, who are not amenable to conventional revascularisation.
The Victor Chang Cardiac Research Institute20 enrolled1 locationACTRN12605000050651